Form 4 for MDXG MIMEDX GROUP, INC.
Accepted 2026-03-06 00:00:00 ET · period of report 2026-03-04 · accession 0001456817-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-06 | 2026-03-04 | MDXG | Capper Joseph H | CEO | A - Grant | $0.00 | +371.1K | 904.7K | +70% | $0 |
| D | 2026-03-06 | 2026-03-04 | MDXG | Capper Joseph H | CEO | A - Grant | $0.00 | +310.6K | 4.09M | +8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-04 | A | A | 371,094 | $0.00 | 904,656 | D | — | — | (F1) Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement. (F2) Includes an aggregate of 4,032 shares acquired on July 31, 2025 and January 30, 2026 pursuant to the MiMedx Group, Inc. Employee Stock Purchase Plan. |
| 2 | Derivative | Stock Options | 2026-03-04 | A | A | 310,574 | $0.00 | 4,087,938 | D | $5.10 · — to 2033-03-03 | 310,574 Common Stock | (F3) The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement. |